Acrivon Therapeutics(ACRV) - 2024 Q1 - Quarterly Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2024 Acrivon Therapeutics, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-41551 82-5125532 (State or Other Jurisdiction (Commission File Number) (IRS Employer of Incorporation) Identification No .) 480 Arsenal Way Suite 100 Watertown, Massachusetts 02472 (Add ...